Sativex reimbursed in Ireland for eligible MS patients with spasticity
Nabiximols, the cannabis-based oral spray sold as Sativex, is available for reimbursement as an adjunctive treatment for moderate to severe spasticity in adults with multiple sclerosis (MS) in Ireland who have not responded as expected from other spasticity medications. Marked by muscle stiffness and involuntary spasms or contractions, spasticity is found in approximately 90% of …